Effects of transgene‐mediated endomorphin‐2 in inflammatory pain
- 1 April 2009
- journal article
- Published by Wiley in European journal of pain
- Vol. 13 (4), 380-386
- https://doi.org/10.1016/j.ejpain.2008.05.008
Abstract
We examined the analgesic properties of endomorphin‐2 expressed in DRG neurons transduced with a non‐replicating herpes simplex virus (HSV)‐based vector containing a synthetic endomorphin‐2 gene cons...This publication has 50 references indexed in Scilit:
- Engineering an endomorphin-2 gene for use in neuropathic pain therapyPain, 2007
- Multiple opiate receptors: déjà vu all over againNeuropharmacology, 2004
- Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivoMolecular Therapy, 2004
- Functional analysis of MOR‐1 splice variants of the mouse mu opioid receptor gene OprmSynapse, 2003
- Herpes vector–mediated expression of proenkephalin reduces bone cancer painAnnals of Neurology, 2002
- Herpes Simplex Virus Type 1 ICP0 Protein Does Not Accumulate in the Nucleus of Primary Neurons in CultureJournal of Virology, 2000
- Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neuronsGene Therapy, 1998
- Basal and touch-evoked fos-like immunoreactivity during experimental inflammation in the ratPain, 1996
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980